Jin T - Search Results

1

Radiotherapy opens the blood-brain barrier and synergizes with anlotinib in treating glioblastoma.

Li PJ, Lai SZ, Jin T, Ying HJ, Chen YM, Zhang P, Hang QQ, Deng H, Wang L, Feng JG, Chen XZ, Guo P, Chen M, Tian Y, Chen YY. Li PJ, et al. Among authors: jin t. Radiother Oncol. 2023 Jun;183:109633. doi: 10.1016/j.radonc.2023.109633. Epub 2023 Mar 23. Radiother Oncol. 2023. PMID: 36963438

2

A phase II trial of Endostar combined with gemcitabine and cisplatin chemotherapy in patients with metastatic nasopharyngeal carcinoma (NCT01612286).

Jin T, Li B, Chen XZ. Jin T, et al. Oncol Res. 2013;21(6):317-23. doi: 10.3727/096504014X13983417587401. Oncol Res. 2013. PMID: 25198661 Clinical Trial.

3

Effect of Prolonged Radiotherapy Treatment Time on Survival Outcomes after Intensity-Modulated Radiation Therapy in Nasopharyngeal Carcinoma.

Li PJ, Jin T, Luo DH, Shen T, Mai DM, Hu WH, Mo HY. Li PJ, et al. Among authors: jin t. PLoS One. 2015 Oct 27;10(10):e0141332. doi: 10.1371/journal.pone.0141332. eCollection 2015. PLoS One. 2015. PMID: 26506559 Free PMC article.

4

Long-term outcomes and failure patterns of patients with nasopharyngeal carcinoma staged by magnetic resonance imaging in intensity-modulated radiotherapy era: The Zhejiang Cancer Hospital's experience.

Jiang F, Jin T, Feng XL, Jin QF, Chen XZ. Jiang F, et al. Among authors: jin t, jin qf. J Cancer Res Ther. 2015 Oct;11 Suppl 2:C179-84. doi: 10.4103/0973-1482.168181. J Cancer Res Ther. 2015. PMID: 26506872 Free article.

5

Evaluation of the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin regimen followed by radiotherapy or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma.

Jin T, Chen XZ, Liu JJ. Jin T, et al. Oncol Lett. 2015 Aug;10(2):1123-1130. doi: 10.3892/ol.2015.3349. Epub 2015 Jun 10. Oncol Lett. 2015. PMID: 26622637 Free PMC article.

6

Repeat biopsy of primary disease negatively affects the outcome of patients with nasopharyngeal cancer treated with definitive intensity-modified radiotherapy: a cohort analysis of 795 patients.

Jiang F, Jin T, Feng XL, Jin QF, Chen XZ. Jiang F, et al. Among authors: jin t, jin qf. Jpn J Clin Oncol. 2016 May;46(5):435-40. doi: 10.1093/jjco/hyw003. Epub 2016 Feb 9. Jpn J Clin Oncol. 2016. PMID: 26864132

7

Management of the N0 neck in recurrent laryngeal squamous cell carcinoma.

Li PJ, Hu WH, Jin T. Li PJ, et al. Among authors: jin t. Mol Clin Oncol. 2016 Jan;4(1):70-76. doi: 10.3892/mco.2015.663. Epub 2015 Oct 29. Mol Clin Oncol. 2016. PMID: 26870361 Free PMC article.

8

A prognostic model combining CD4/CD8 ratio and N stage predicts the risk of distant metastasis for patients with nasopharyngeal carcinoma treated by intensity modulated radiotherapy.

Tao CJ, Chen YY, Jiang F, Feng XL, Jin QF, Jin T, Piao YF, Chen XZ. Tao CJ, et al. Among authors: jin t, jin qf. Oncotarget. 2016 Jul 19;7(29):46653-46661. doi: 10.18632/oncotarget.9695. Oncotarget. 2016. PMID: 27270307 Free PMC article.

9

ABO blood group is a predictor of survival in patients with laryngeal cancer.

Jin T, Li PJ, Chen XZ, Hu WH. Jin T, et al. Chin J Cancer. 2016 Oct 13;35(1):90. doi: 10.1186/s40880-016-0152-9. Chin J Cancer. 2016. PMID: 27733208 Free PMC article.

10

The C-reactive Protein/Albumin Ratio Is an independent Prognostic Factor for Overall Survival in Patients with Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiotherapy.

Tao CJ, Chen YY, Jiang F, Feng XL, Jin QF, Jin T, Piao YF, Chen XZ. Tao CJ, et al. Among authors: jin t, jin qf. J Cancer. 2016 Oct 11;7(14):2005-2011. doi: 10.7150/jca.16210. eCollection 2016. J Cancer. 2016. PMID: 27877215 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,525 results

Search Page

Filters